Clinical characteristics of Chikungunya infection and its impact on the quality of life of patients in health care centers in the Central Depart- ment in August 2023
Abstract
Introduction: Chikungunya disease is an arboviroais, caused by an Alfavirus virus of the Togaviridae family, transmitted by Aedes aegypti or Aedes albopictus mosquitoes. Ob- jective: To determine the clinical characteristics and quality of life after Chikungunya virus (CHIKV) infection.
Materials and Methods: observational, descriptive, cross-sectional study of patients with CHIKV during the month of August 2023. A questionnaire was carried out, sociodemographic data, diagnosis of CHIKV infection, duration of the disease and clinical manifestations were measured. The Spanish version of the “SF-36 Quality of Life Questionnaire” was included.
Results: A group of 192 patients was evaluated during the study period. The average age of the study population was 36 +/- 13.62 years and 53.65% were female. Women reported worse health status (M: 68.93% vs. M: 55.06%)in general, and this increased with age. The most frequent symptoms were fever and polyarthralgia.
Conclusion: All individuals reported some type of impairment in quality of life, particularly in the domains of physical role, vitality and pain.
Downloads
References
(1) Chikungunya [Internet]. Who. int. 15 de septiembre de 2020. Disponible en: https://www.who.int/es/news-room/fact-sheets/detail/chikungunya
(2) Ministerio de Salud Pública y Bienestar Social. Guía de manejo clínico y tratamiento de la Enfermedad por virus Chikunguya. 2023. https://fpgo.org.py/wpcontent/uploads/2023/04/Guia-demanejo-clinico-de-la-chikungunyaMSPyBS-31032023.pdf
(3) Staples JE, Breiman RF, Powers AM. Chikungunya fever: an epide miological review of a re-emerging infectious disease. Clin Infect Dis. 2009 Sep 15;49(6):942-8. doi: https://doi.org/10.1086/605496.
(4) Alerta Epidemiológica: Aumento de casos y defunciones por chikunguña en la Región de las Américas [Internet]. OPS.org. [citado el 9 de julio de 2023]. Disponible en: https://www.paho.org/es/documentos/alerta-epidemiologica-aumento-casos-defunciones-por-chikunguna-region-americas
(5) Benítez I, Torales M, Peralta K, Dominguez C, Grau L, Sequera G, Morel Z. Caracterización clínica y epidemiológica de la epidemia de Chikungunya en el Paraguay. An. Fac. Cienc. Méd. (Asunción) [Internet]. 2023 Aug [cited 2024 June 05];56(2):18-26. Available from: http://scielo.iics.una.py/scielo.php?script=sci_arttext&pid=S1816-89492023000200018&lng=en. https://doi.org/10.18004/anales/2023.056.02.18.
(6) Guillermo S. ¿Por qué esta gran epidemia de CHIKV? ¿Qué paso del dengue? Un. fac. Cienc. Medicina. (Asunción) [Internet]. 2023 abril [citado el 2023 junio 06]; 56(1): 19-24. Disponible en: http://scielo.iics.una.py/scielo.php?script=sci_arttext&pid=S181689492023000100019&lng=en. https://doi.org/10.18004/anales/2023.056.01.19.
(7) Narsimulu G, Prabhu N. Post-chikungunya chronic arthritis. J Assoc Physicians India. 2011 Feb;59:81.
(8) Dupuis-Maguiraga L, Noret M, Brun S, Le Grand R, Gras G, Roques P. Chikungunya disease: infection-associated markers from the acute to the chronic phase of arbovirus-induced arthralgia. PLoS Negl Trop Dis. 2012;6(3):e1446. doi: 10.1371/journal.pntd.0001446.
(9) Lloves Schenone NM. Artralgias persistentes luego de infección por virus Chikungunya. Rev. Argent. Reumatol. [Internet]. 19 de diciembre de 2022 [citado 16 de julio de 2023];33(4):248 -253. Disponible en: https://www.ojs.reumatologia.org.ar/index.php/revistaSAR/article/view/370
(10) González-Colonia C, Agudelo-Mejia K, Prieto-Andica V, Rivera- Zapata JA, Usma-Valencia AF, Rodriguez-Morales AJ, et al. Reumatismo inflamatorio crónico post Chikungunya: Una visión etnográfica del impacto social de la enfermedad en una cohorte de 2 años de seguimiento en Colombia [Internet]. Edu.co. [citado el 17 de julio de 2023]. Disponible en: https://repositorio.utp.edu.co/bitstreams/6ffa4ab0-f230-488c-bc12-dc9946761efe/ download
(11) Chikungunya: se está experimentando un “tsunami de pacientes” en Reumatología [Internet]. La Nación. 2023 [citado el 17 de julio de 2023]. Disponible en: https://www.lanacion.com.py/pais/2023/03/30/chikungunya-se-esta-experimentando-un-tsunami-de-pacientes-en-reumatologia/
(12) Gonzalez G. Departamento de Reumatología de la FCM-UNA sigue con alta demanda de pacientes post chikungunya [Internet]. Una.py. [citado el 17 de julio de 2023]. Disponible en: https://www.med.una.py/index.php/hospital-hc/noticias-del-hospital/4273-departamento-de-reumatolog%C3%ADa-de-la-fcm-una-sigue-con-alta-demanda-de-pacientes-post-chikungunya
(13) Alonso J, Prieto L, Antó JM. La versión española del SF-36 Health Survey (Cuestionario de Salud SF-36): un instrumento para la medida de los resultados clínicos. Medicina Clínica 1995; 104(20):771-776.
(14) Ware JE Jr. SF-36 health survey update. Spine (Phila Pa 1976). 2000 Dec 15;25(24):3130-9. doi: https://doi.org/10.1097/00007632-200012150-00008.
(15) Vásquez-Yañez J, Guzmán-Muñoz E. Calidad de vida, Burnout e indicadores de salud en enfermeras/os que trabajan con turnos rotativos. Univ. Salud [Internet]. 2021 Dec [cited 2024 June 05];23(3):240-247. Available from: http://www.scielo.org.co/ scielo.php?script=sci_arttext&pid=S0124- 71072021000300240&lng=en. Epub Sep 01, 2021. https://doi.org/10.22267/rus.212303.237.
(16) Doran C, Elsinga J, Fokkema A, Berenschot K, Gerstenbluth I, Duits A, et al. Long-term Chikungunya sequelae and quality of life 2.5 years post-acute disease in a prospective cohort in Curaçao. PLoS Negl Trop Dis. 2022 Mar 1;16(3):e0010142. doi: https://doi.org/10.1371/journal.pntd.0010142.
(17) Cavalcante AFL, Okano AH, Micussi MT, Souza CG de, Passos JOS, Morya E, et al.. Chronic Chikungunya arthralgia reduces functionality, quality of life and occupational performance: descriptive cross-sectional study. BrJP [Internet]. 2022Jul;5(3):233–8. Available from: https://doi.org/10.5935/2595-0118.20220047-en
(18) Abella J, Rojas A, Rojas C, Rondon F, Medina Y, Peña M, et al. Clinical and immunological features of post-chikungunya virus chronic arthritis and its effect on functional ability and quality of life in a cohort of colombian patients. Rev colom reumatol. 2019;26(4):253-259. Disponible en: https://www.elsevier.es/en-revista-revista-colombiana-reumatologia-english-edition--474-pdf-S2444440519301244
(19) Couturier E, Guillemin F, Mura M, Léon L, Virion JM, Letort MJ, et al. Impaired quality of life after chikungunya virus infection: a 2-year follow-up study. Rheumatology (Oxford). 2012 Jul;51(7):1315-22. doi: https://doi.org/10.1093/rheumatology/kes015.
(20) Rodriguez-Morales AJ, Gil-Restrepo AF, Ramírez-Jaramillo V, Montoya-Arias CP, Acevedo-Mendoza WF, Bedoya-Arias JE, et al. Post-chikungunya chronic inflammatory rheumatism: results from a retrospective follow-up study of 283 adult and child cases in La Virginia, Risaralda, Colombia. F1000Res. 2016 Mar 16;5:360. doi: https://doi.org/10.12688/f1000research.8235.2.
Copyright (c) 2024 Emilio Villalba, Rocio Romero, María Eugenia Acosta de Hetter
This work is licensed under a Creative Commons Attribution 4.0 International License.
